Create your own ideas about Peace, Planet and Profit

NextRNA Therapeutics to Participate in Upcoming BioPharm America and Chardan’s 6th Annual Genetic Medicines Conference

23



BOSTON–()–NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop novel and transformative therapeutics, today announced management’s participation in two upcoming investor conferences.

BioPharm America

September 28 – 29, 2022

Boston (In-person event)

JS Cleiftie, MS, MBA, Chief Business Officer and Head of Finance

Available for one-on-one meetings

Chardan’s 6th Annual Genetic Medicines Conference

October 3 – 4, 2022

NYC (In-person event)

Dominique Verhelle, PhD, MBA, Co-Founder, Chief Executive Officer and Chief Scientific Officer

Corporate Presentation: Mon., Oct. 3, 10:30 – 10:55 am

Long Non-Coding RNA Panel: Mon., Oct. 3, 3:00 – 3:45 pm

About NextRNA Therapeutics

NextRNA is a biotechnology company unlocking the potential of non-coding RNAs to develop transformative medicines for multiple diseases. The company is leveraging its proprietary technology platform to identify non-coding RNAs and their interacting proteins responsible for disease, and to develop selective small molecules to disrupt these interactions.

For more information, please visit www.nextrnatx.com.

Comments are closed, but trackbacks and pingbacks are open.